National Center for Child Health and Development
National Center for Child Health and Development
Tokyo, Japan5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) | Crohn disease, Digestive System Diseases, Pediatric ulcerative colitis, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, pediatric Crohn disease, ulcerative colitis | Recruiting | Phase 3 | 2026-10-07 | NCT04844606 | |
| A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Axatilimab Monotherapy in Japanese Participants With Recurrent or Refractory Active Chronic Graft-Versus-Host Disease | Bronchiolitis Obliterans, bronchial disorder, bronchiolitis, bronchiolitis obliterans syndrome, bronchitis, cryptogenic organizing pneumonia, graft versus host disease, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Active, not recruiting | Phase 3 | 2026-10-05 | NCT06263478 | |
| A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, Infant, Premature, Diseases, Lung Injury, Ventilator-Induced Lung Injury, bronchopulmonary dysplasia, eye disorder, lung disorder, respiratory system disorder, retinal disorder, retinopathy of prematurity | Active, not recruiting | Phase 2 | 2026-08-03 | NCT03253263 | |
| A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome | Childhood Idiopathic Nephrotic Syndrome, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, nephrosis, nephrotic syndrome, urinary system disorder | Active, not recruiting | Phase 3 | 2025-12-15 | NCT05627557 | |
| International Registry of Congenital Portosystemic Shunt (IRCPSS) | 46,XX disorder of sex development, Brain Diseases, Metabolic, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hepatic Insufficiency, Hyperammonemia, Hyperandrogenism, Insulin Resistance, Liver Neoplasms, Male Urogenital Diseases, Neoplasms by Site, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Rare Diseases, Urogenital Abnormalities, Urogenital Diseases, adrenogenital syndrome, brain disorder, cardiovascular disorder, central nervous system disorder, congenital portosystemic shunt, disorder of sexual differentiation, endocrine system disorder, glucose metabolism disease, gonadal disorder, hepatic encephalopathy, hepatopulmonary syndrome, hyperinsulinism, hypertensive disorder, hypoglycemia, liver disorder, liver failure, lung disorder, metabolic disease, neoplasm, nervous system disorder, pulmonary hypertension, respiratory system disorder, vascular disorder, vascular malformation | Enrolling by invitation | Not stated | 2025-06-18 | NCT06041906 |